Kohlberg Kravis Roberts & Co. L.P.
NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$5.04B2026 Q3
Positions103
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.95.7%
Kohlberg Kravis Roberts & Co. L.P. reported 103 positions worth $5.04B as of September 30, 2026 (13F filed November 13, 2026). Largest holding: BTSG (30.2%).
10 / 103 positions shown
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | BTSG | $1.52B | 30.23% | 26,829,880 | — | — | +25.8% | |
| ▸ 2 | HSIC | $1.31B | 26.09% | 15,652,032 | — | — | +1.2% | |
| ▸ 3 | BBIO | $543.6M | 10.79% | 8,260,971 | — | — | +17.6% | |
| ▸ 4 | NIQ | $510.7M | 10.14% | 30,022,789 | — | — | +10.4% | |
| ▸ 5 | CRGY | $369.4M | 7.33% | 28,655,357 | — | — | -10.3% | |
| ▸ 6 | BV | $219.1M | 4.35% | 21,533,123 | — | — | -6.3% | |
| ▸ 7 | GMRS | $142.4M | 2.83% | 14,785,611 | — | — | +19.8% | |
| ▸ 8 | NCLH 0.75 09-15-30 | $96.5M | 1.92% | $114.5M principal | — | — | — | |
| ▸ 9 | KREF | $62.1M | 1.23% | 10,000,001 | — | — | -12.7% | |
| ▸ 10 | NCLH 0.875 04-15-30 | $39.7M | 0.79% | $43.5M principal | — | — | — |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Kohlberg Kravis Roberts & Co. L.P. hold as of Q3 2026?
Kohlberg Kravis Roberts & Co. L.P. reported 103 positions worth $5.04B in its Q3 2026 13F filing. Largest positions: BTSG (30.2%), HSIC (26.1%), BBIO (10.8%), NIQ (10.1%) and CRGY (7.3%).
What did Kohlberg Kravis Roberts & Co. L.P. buy in Q3 2026?
No previous quarter is available yet; the comparison appears with the next filing.
What did Kohlberg Kravis Roberts & Co. L.P. sell in Q3 2026?
No previous quarter is available yet.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.